Article Details
Retrieved on: 2024-04-30 15:57:28
Tags for this article:
Click the tags to see associated articles and topics
Summary
Denovo Biopharma LLC is advancing regenerative medicine in cancer treatment by developing a biomarker-guided gene therapy, DB107, for high-grade gliomas, including glioblastoma, with CIRM funding, aiming to improve patient outcomes through precision medicine.
Article found on: www.fox44news.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here